Xiaoqinglong granules as add-on therapy for asthma: Latent class analysis of symptom predictors of response

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zha, Qinglin ^a   Lin, Seqi ^a   Zhang, Chi ^b   Chang, Christopher ^c   Xue, Hanrong ^a   Lu, Cheng ^b   Jiang, Miao ^b   Liu, Yan ^b   Xiao, Zuke ^d   Liu, Weiyou ^e   Shang, Yunfei ^f   Chen, Jianjian ^g   Wen, Minyong ^h   Lu, Aiping ^b,i  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d People's Hospital of Jiangxi Province   (China)

^e GANNAN MEDICAL UNIVERSITY   (China)

^f NANTONG UNIVERSITY   (China)

^g Nanchang Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^h GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

ⁱ HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; CHINESE DRUG; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; UNCLASSIFIED DRUG; XIAOQINGLONG GRANULE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; ASTHMA; AVERSION; CHEST TIGHTNESS; COUGHING; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 84874517821     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/759476     Document Type: Article

References (55)

1. Chang C., Asthma in children and adolescents: a comprehensive approach to diagnosis and management. Clinical Reviews in Allergy and Immunology 2011 1 40 2-s2.0-79952987330 10.1007/s12016-011-8261-3
2. Louie S., Morrissey B. M., Kenyon N. J., Albertson T. E., Avdalovic M., The critically Ill asthmatic-from ICU to discharge. Clinical Reviews in Allergy and Immunology 2011 1 15 2-s2.0-79955788207 10.1007/s12016-011-8274-y
3. Zeki A. A., Kenyon N. J., Yoneda K., Louie S., The adult asthmatic. Clinical Reviews in Allergy and Immunology 2011 1 18 2-s2.0-79952697084 10.1007/s12016-011-8260-4
4. Vatti R. R., Teuber S. S., Asthma and pregnancy. Clinical Reviews in Allergy and Immunology 2012 43 1-2 45 56 10.1007/s12016-011-8277-8
5. Clark C. E., Arnold E., Lasserson T. J., Wu T., Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysis. Primary Care Respiratory Journal 2010 19 4 307 314 2-s2.0-77956080128 10.4104/pcrj.2010.00041
6. Passalacqua G., Bousquet P. J., Carlsen K. H., Kemp J., Lockey R. F., Niggemann B., Pawankar R., Price D., Bousquet J., ARIA update: I-systematic review of complementary and alternative medicine for rhinitis and asthma. The Journal of Allergy and Clinical Immunology 2006 117 5 1054 1062 2-s2.0-33646155103 10.1016/j.jaci.2005.12.1308
7. Li X. M., Traditional Chinese herbal remedies for asthma and food allergy. The Journal of Allergy and Clinical Immunology 2007 120 1 25 31 2-s2.0-34250891886 10.1016/j.jaci.2007.04.030 (Pubitemid 46990507)
8. Chen F. P., Chen F. J., Jong M. S., Tsai H. L., Wang J. R., Hwang S. J., Modern use of Chinese herbal formulae from Shang-Han Lun. Chinese Medical Journal 2009 122 16 1889 1894 2-s2.0-70349528209 10.3760/cma.j.issn.0366-6999. 2009.16.010
9. Zhang Z., Mitchell C., Feng Y., Wiseman N., Shang Hán Lùn 1999 Paradigm Publications
10. Flaws B., Sionneau P., The Treatment of Modern Western Medical Diseases with Chinese Medicine: A Textbook & Clinical Manual 2001 Blue Poppy Press
11. Wang P., Zhong Yi Shi Da Ming Fang 1998 Beijing, China Zhongguo Zhong Yi Yao Chu Ban She
12. China Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China 2005 Chemical lndustry Press
13. Yang H. L., P H. L. J., Li Y. H., Guo M. Z., A system evaluation on randomized control trials: xiaoqinglong decoction in treatment of asthma. Journal of Beijing University of Traditional Chinese Medicine 2008 15 25 29
14. Xiong X. J., Wang J., Discussion of related problems in herbal prescription science based on objective indications of herbs. Journal of Chinese Integrative Medicine 2010 8 1 20 24 2-s2.0-75749134544 10.3736/jcim20100104
15. Byun J. S., Yang S. Y., Jeong I. C., Hong K. E., Kang W., Yeo Y., Park Y. C., Effects of So-Cheong-Ryong-Tang and Yeon-gyo-pae-dok-san on the common cold: randomized, double blind, placebo controlled trial. Journal of Ethnopharmacology 2011 133 2 642 646 2-s2.0-78651382463 10.1016/j.jep.2010.10. 056
16. Ko E., Rho S., Cho C., Choi H., Ko S., Lee Y., Hong M. C., Shin M. K., Jung S. G., Bae H., So-Cheong-Ryong-Tang, tradititional Korean medicine, suppresses Th2 lineage development. Biological and Pharmaceutical Bulletin 2004 27 5 739 743 2-s2.0-16644394337 10.1248/bpb.27.739 (Pubitemid 41694684)
17. Kung Y. Y., Chen Y. C., Hwang S. J., Chen T. J., Chen F. P., The prescriptions frequencies and patterns of Chinese herbal medicine for allergic rhinitis in Taiwan. Allergy 2006 61 11 1316 1318 2-s2.0-33749057774 10.1111/j.1398-9995.2006.01152.x (Pubitemid 44465592)
18. Takeuchi Y., Nishimura Y., Yoshikawa T., A comparison between Chinese blended medicine "Shoseiryuto" tranilast and ketotifen on the anti-allergic action in the guinea pigs. Japanese Journal of Allergology 1985 34 6 387 393 2-s2.0-0021833553 (Pubitemid 15027448)
19. Yamada H., Nagai T., Nakao M., Shimizu Y., Kodera Y., Oh-Ishi M., Maeda T., Proteomic analysis of anti-inflammatory effects of a kampo (Japanese Herbal) medicine "shoseiryuto (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. Evidence-based Complementary and Alternative Medicine 2011 2011 13 2-s2.0-79955079209 10.1093/ecam/nep151 604196
20. Amagaya S., Iizuka A., Makino B., Kubo M., Komatsu Y., Cheng F. C., Ruo T. I., Itoh T., Terasawa K., General pharmacological properties of Sho-seiryu-to (TJ-19) extracts. Phytomedicine 2001 8 5 338 347 2-s2.0-0034780901 (Pubitemid 32983053)
21. Nagai T., Arai Y., Emori M., Nunome S. Y., Yabe T., Takeda T., Yamada H., Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. International Immunopharmacology 2004 4 10-11 1353 1365 2-s2.0-4143061520 10.1016/j.intimp.2004.05.021 (Pubitemid 39094409)
22. Tanno Y., Shindoh Y., Takishima T., Modulation of human basophil growth in vitro by Xiao-Qing-Long-Tang (Syo-seiryu-to), Chai-Pu-Tang (Saiboku-to), Qing-Fei-Tang (Seihai-to), baicaalein and ketotifen. American Journal of Chinese Medicine 1989 17 1-2 45 50 2-s2.0-0024386034 (Pubitemid 19214602)
23. Nyunt A. K., Takeuchi Y., Yokomuro K., Miyanaga Y., Comparative studies on the antiallergic effects of kampo medicines used for the therapy of respiratory diseases. Japanese Journal of Allergology 1995 44 4 503 512 2-s2.0-0029070348
24. Sakaguchi M., Iizuka A., Yuzurihara M., Ishige A., Komatsu Y., Matsumiya T., Takeda H., Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain. Methods and Findings in Experimental and Clinical Pharmacology 1996 18 1 41 47 2-s2.0-0029879475 (Pubitemid 26101297)
25. Kao S. T., Lin C. S., Hsieh C. C., Hsieh W. T., Lin J. G., Effects of xiao-qing-long-tang (XQLT) on bronchoconstriction and airway eosinophil infiltration in ovalbumin-sensitized guinea pigs: in vivo and in vitro studies. Allergy 2001 56 12 1164 1171 2-s2.0-0035180547 10.1034/j.1398-9995.2001.00982.x (Pubitemid 33086977)
26. Kirn H. M., Yoon G. S., Seo J. U., Moon G., Kirn H. R., Shin T. Y., Inhibition of mast cell-mediated anaphylaxis by Sochungryong-Tang. American Journal of Chinese Medicine 2000 28 1 69 76 2-s2.0-0033657375
27. Velazquez J. R., Teran L. M., Chemokines and their receptors in the allergic airway inflammatory process. Clinical Reviews in Allergy and Immunology 2011 41 1 76 88
28. Kao S. T., Wang S. D., Lin L. J., Chen C. L., Lee S. C., Lin C. C., Wang J. Y., Xiao-Qing-Long-Tang attenuates allergic airway inflammation and remodeling in repetitive Dermatogoides pteronyssinus challenged chronic asthmatic mice model. Journal of Ethnopharmacology 2012 142 2 531 538 10.1016/j.jep.2012.05.033
29. Kim J., Natarajan S., Bae H., Jung S. K., Cruikshank W., Remick D. G., Herbal medicine treatment reduces inflammation in a murine model of cockroach allergeninduced asthma. Annals of Allergy, Asthma and Immunology 2011 107 2 154 162 2-s2.0-79960894958 10.1016/j.anai.2011.05.001
30. Makino T., Inagaki T., Komatsu K. I., Kano Y., Pharmacokinetic interactions between Japanese traditional medicine (kampo) and modern medicine (III). Effect of Sho-seiryu-to on the pharmacokinetics of azelastine hydrochloride in rats. Biological and Pharmaceutical Bulletin 2004 27 5 670 673 2-s2.0-16644386248 10.1248/bpb.27.670 (Pubitemid 41694668)
31. Makino T., Mizuno F., Mizukami H., Does a kampo medicine containing schisandra fruit affect pharmacokinetics of nifedipine like grapefruit juice? Biological and Pharmaceutical Bulletin 2006 29 10 2065 2069 2-s2.0-33749430489 10.1248/bpb.29.2065 (Pubitemid 44510810)
32. Shimada T., Kondoh M., Motonaga C., Kitamura Y., Cheng L., Shi H., Enomoto T., Tsuruta D., Ishii M., Kobayashi H., Enhancement of Anti-Allergic effects mediated by the kampo medicine shoseiryuto (Xiao-Qing-Long-Tang in Chinese) with lysed enterococcus faecalis FK-23 in mice. Asian Pacific Journal of Allergy and Immunology 2010 28 1 59 66 2-s2.0-77954546512
33. Ikeda Y., Iizuka A., Amagaya S., Ishige A., Komatsu Y., Fujihira E., Anti-type I allergic mechanisms of mao-bushi-saishin-to in mice. Japanese Journal of Pharmacology 2000 82 1 29 33 2-s2.0-0033955896 10.1254/jjp.82.29 (Pubitemid 30098647)
34. Yafune A., Cyong J. C., Population pharmacokinetic analysis of ephedrine in Kampo prescriptions: a study in healthy volunteers and clinical use of the pharmacokinetic results. International Journal of Clinical Pharmacology Research 2001 21 2 95 102 2-s2.0-0035685971 (Pubitemid 34074276)
35. Chan K. H., Hsu M. C., Chen F. A., Hsu K. F., Elimination of ephedrines in urine following administration of a Sho-seiryu-to preparation. Journal of Analytical Toxicology 2009 33 3 162 166 2-s2.0-65749113648
36. Chen J. W., A study on the quality of life for asthma patients with Xiao Qing Long Tang. Fujian Journal of Traditional Chinese Medicine 2011 42 13 14
37. Brand E., A Clinician's Guide to Using Granule Extracts 2010 Blue Poppy Press
38. State Food and Drug Administration of China, Supplementary Rules for TCM Registration. http://www.sfda.gov.cn/
39. State Food and Drug Administration of China, Overview on Registration Administration of Traditional Chinese Medicines (TCM) in China. http://www.who.int/medicines/areas/quality-safety/regulation-legislation/icdra/ 4-China-RevisingRegulatoryFramework-HerbalMedicines.pdf
40. National Institutes of Health, Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health National Heart, Lung and Blood Institute, http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.pdf
41. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. http://www.ginasthma.org/
42. State Administration of Traditional Chinese Medicine of the People's Republic of China, Criteria of Diagnosis and Therapeutic Effect of Disease and Syndromes in Traditional Chinese Medicine 1994 Nanjing, China Nanjing University Press
43. Asthma Group of Chinese Society of Respiratory Diseases, The guideline of asthma treatment and prevention. Chinese Journal of Tuberculosis and Respiratory Diseases 2003 31 3 132 138
44. Liu B. W., T B. W., Yao C., Yan S., He L., Xie Y., Mu Z., The central randomization system in multi-center clinical trials. Chinese Journal of New Drugs and Clinical Remedies 2006 25 931 935
45. Bateman E. D., Hurd S. S., Barnes P. J., Bousquet J., Drazen J. M., FitzGeralde M., Gibson P., Ohta K., O'Byrne P., Pedersen S. E., Pizzichini E., Sullivanee S. D., Wenzel S. E., Zar H. J., Global strategy for asthma management and prevention: GINA executive summary. European Respiratory Journal 2008 31 1 143 178 2-s2.0-39049170984 10.1183/09031936.00138707
46. Nathan R. A., Sorkness C. A., Kosinski M., Schatz M., Li J. T., Marcus P., Murray J. J., Pendergraft T. B., Development of the asthma control test: a survey for assessing asthma control. The Journal of Allergy and Clinical Immunology 2004 113 1 59 65 2-s2.0-0347302909 10.1016/j.jaci.2003.09.008 (Pubitemid 38096162)
47. Schatz M., Sorkness C. A., Li J. T., Marcus P., Murray J. J., Nathan R. A., Kosinski M., Pendergraft T. B., Jhingran P., Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. The Journal of Allergy and Clinical Immunology 2006 117 3 549 556 2-s2.0-33644764664 10.1016/j.jaci.2006.01.011 (Pubitemid 43340217)
48. Lanza S. T., Collins L. M., Lemmon D. R., Schafer J. L., PROC LCA: a SAS procedure for latent class analysis. Structural Equation Modeling 2007 14 4 671 694 2-s2.0-36448954349
49. Li X. M., Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine. The Mount Sinai Journal of Medicine 2011 78 697 716
50. Wen M. C., Wei C. H., Hu Z. Q., Srivastava K., Ko J., Xi S. T., Mu D. Z., Du J. B., Li G. H., Wallenstein S., Sampson H., Kattan M., Li X. M., Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. The Journal of Allergy and Clinical Immunology 2005 116 3 517 524 2-s2.0-24644479841 10.1016/j.jaci.2005.05.029 (Pubitemid 41267121)
51. Simon R., Patient subsets and variation in therapeutic efficacy. British Journal of Clinical Pharmacology 1982 14 4 473 482 2-s2.0-0020358354 (Pubitemid 13147490)
52. Wang C., Cao B., Liu Q. Q., Zou Z. Q., Liang Z. A., Gu L., Dong J. P., Liang L. R., Li X. W., Hu K., He X. S., Sun Y. H., An Y., Yang T., Cao Z. X., Guo Y. M., Wen X. M., Wang Y. G., Liu Y. L., Jiang L. D., Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Annals of Internal Medicine 2011 155 217 225
53. He W., Xie Y., Wang Y., Thought on several problems of clinical revaluationof post-marketing herb research. Zhongguo Zhong Yao Za Zhi 2010 35 12 1641 1643 2-s2.0-77957086909 10.4268/cjcmm20101230
54. He W., Xie Y., Wang Y., Postmarketing herbs clinical evaluation should concern about re-evaluating symptoms. Zhongguo Zhong Yao Za Zhi 2010 35 11 1498 1500 2-s2.0-77956101449 10.4268/cjcmm20101131
55. Liu L., Leung E. L., Tian X., Perspective: the clinical trial barriers. Nature 2011 480 7378 S100 10.1038/480S100a